Published in Mol Cell Biol on January 22, 2007
Discovering sequence motifs with arbitrary insertions and deletions. PLoS Comput Biol (2008) 4.10
Transcriptional control of endothelial cell development. Dev Cell (2009) 2.12
Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood (2008) 2.00
VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol (2010) 1.49
LIM-domain-only proteins in cancer. Nat Rev Cancer (2013) 1.19
A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development. Development (2008) 1.05
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. Am J Clin Pathol (2009) 0.94
Endothelial permeability and VE-cadherin: a wacky comradeship. Cell Adh Migr (2014) 0.93
Reverse genetics screen in zebrafish identifies a role of miR-142a-3p in vascular development and integrity. PLoS One (2012) 0.91
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. Blood (2012) 0.90
Transforming growth factor-β1 inhibits trophoblast cell invasion by inducing Snail-mediated down-regulation of vascular endothelial-cadherin protein. J Biol Chem (2013) 0.87
Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells. PLoS One (2012) 0.86
Vascular potential of human pluripotent stem cells. Arterioscler Thromb Vasc Biol (2010) 0.85
VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2. PLoS One (2010) 0.83
Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes. J Biomed Sci (2010) 0.82
Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles. J Drug Deliv (2012) 0.82
Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1. J Virol (2008) 0.81
Endothelial permeability and VE-cadherin: a wacky comradeship. Cell Adh Migr (2013) 0.80
GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2. Angiogenesis (2013) 0.80
Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy. Hum Mutat (2014) 0.80
tal1 Regulates the formation of intercellular junctions and the maintenance of identity in the endocardium. Dev Biol (2013) 0.79
Vascular endothelial cadherin modulates renal interstitial fibrosis. Nephron Exp Nephrol (2011) 0.79
Drosophila LIM-only is a positive regulator of transcription during thoracic bristle development. Genetics (2008) 0.79
LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling. Oncotarget (2016) 0.78
CCM1 and the second life of proteins in adhesion complexes. Cell Adh Migr (2014) 0.75
Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration. Arterioscler Thromb Vasc Biol (2017) 0.75
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 15.78
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell (1999) 7.33
The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J (1997) 6.36
Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature (1995) 5.42
Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol (2004) 5.37
Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res (1994) 5.14
Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev (2003) 4.89
The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell (1996) 4.35
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A (1995) 3.47
The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol (1995) 3.27
Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature (2003) 3.25
The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J (1996) 2.83
Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J (2004) 2.62
The SCL gene specifies haemangioblast development from early mesoderm. EMBO J (1998) 2.47
The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood (1994) 2.17
Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev (1998) 2.16
The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci U S A (2003) 2.12
Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol (1998) 2.08
Role of vascular endothelial-cadherin in vascular morphogenesis. Development (1999) 2.06
SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp Hematol (2004) 2.02
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol (1994) 2.00
Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol (2003) 1.92
SCL assembles a multifactorial complex that determines glycophorin A expression. Mol Cell Biol (2004) 1.89
Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development (1999) 1.80
Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. Blood (2005) 1.76
ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol Cell Biol (2005) 1.70
Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res (2004) 1.68
Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development (2003) 1.67
The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci U S A (2000) 1.65
ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J (2006) 1.63
Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev (2003) 1.62
Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec (2002) 1.56
SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. Blood (2005) 1.37
Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J Biol Chem (1998) 1.30
Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol (1999) 1.29
Expression of TAL-1 proteins in human tissues. Blood (1995) 1.29
mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol (2000) 1.24
p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene (1999) 1.23
Chromatin immunoselection defines a TAL-1 target gene. EMBO J (1998) 1.22
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts. Mol Cell Biol (2000) 1.22
The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene (2005) 1.12
ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin. Oncogene (2000) 1.11
Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood (2004) 1.00
A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis. Blood (2006) 0.94
Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1. Mol Cell Biol (2004) 0.91
The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis. J Cell Sci (2004) 0.87
PU.1/Spi-1 binds to the human TAL-1 silencer to mediate its activity. J Mol Biol (2005) 0.83
TAL-1 protein expression in vascular lesions. J Pathol (1997) 0.82
Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science (2009) 2.96
Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology (2011) 2.51
The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta (2008) 2.26
Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta (2007) 1.87
Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep (2011) 1.86
The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem (2008) 1.66
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J (2007) 1.63
Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol (2008) 1.59
Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. J Leukoc Biol (2009) 1.57
The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS (2013) 1.56
Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab (2007) 1.54
Hereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation. J Allergy Clin Immunol (2011) 1.45
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS (2012) 1.44
Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol (2008) 1.41
Circadian clock-coordinated 12 Hr period rhythmic activation of the IRE1alpha pathway controls lipid metabolism in mouse liver. Cell Metab (2010) 1.41
Transcriptional activation of interleukin-8 by beta-catenin-Tcf4. J Biol Chem (2002) 1.40
Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods (2011) 1.40
Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci (2008) 1.36
How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol (2002) 1.35
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem (2008) 1.32
Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells. J Cell Sci (2002) 1.31
Elastin haploinsufficiency induces alternative aging processes in the aorta. Rejuvenation Res (2008) 1.26
Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett (2003) 1.26
Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer (2009) 1.26
Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol (2007) 1.26
Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem (2004) 1.25
Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm (2011) 1.25
Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J Immunol (2003) 1.21
Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res (2005) 1.20
Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions. Cell Mol Neurobiol (2005) 1.19
Transient muscle paralysis disrupts bone homeostasis by rapid degradation of bone morphology. Bone (2009) 1.18
Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot Cell (2009) 1.17
Angiogenesis: the VE-cadherin switch. Trends Cardiovasc Med (2006) 1.17
Cdk1 and Cdk2 activity levels determine the efficiency of replication origin firing in Xenopus. EMBO J (2008) 1.16
Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog (2010) 1.16
The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene (2005) 1.12
Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul Pharmacol (2002) 1.12
The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer (2011) 1.11
A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res (2007) 1.11
JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation. J Cell Biol (2008) 1.09
Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J Cell Sci (2006) 1.07
Molecular mechanism of systemic delivery of neural precursor cells to the brain: assembly of brain endothelial apical cups and control of transmigration by CD44. Stem Cells (2008) 1.04
The motor protein myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts. Mol Cell Biol (2010) 1.03
N-cadherin deficiency impairs pericyte recruitment, and not endothelial differentiation or sprouting, in embryonic stem cell-derived angiogenesis. Exp Cell Res (2005) 1.02
Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: a new target cell type for the immunodeficiency virus-1? FASEB J (2002) 1.01
CCL2 disrupts the adherens junction: implications for neuroinflammation. Lab Invest (2012) 1.01
Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa. PLoS Pathog (2012) 1.00
Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther (2010) 1.00
Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe? BMC Neurosci (2014) 1.00
Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS One (2010) 1.00
Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys (2008) 1.00
Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells. Mol Pharmacol (2008) 0.99
Regulation of cerebral endothelial cell morphology by extracellular calcium. Phys Med Biol (2007) 0.98
Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods (2012) 0.98
Uptake and cytotoxicity of citrate-coated gold nanospheres: Comparative studies on human endothelial and epithelial cells. Part Fibre Toxicol (2012) 0.98
Angiotensin II facilitates breast cancer cell migration and metastasis. PLoS One (2012) 0.97
Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog (2008) 0.97
Guanine nucleotide-binding protein Gαi2: a new partner of claudin-5 that regulates tight junction integrity in human brain endothelial cells. J Cereb Blood Flow Metab (2012) 0.97
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide. J Biotechnol (2011) 0.96
Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. Eur J Cell Biol (2010) 0.95
Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J Immunol (2008) 0.95
Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest Ophthalmol Vis Sci (2002) 0.95
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. Eur J Pharm Biopharm (2010) 0.95
Protocadherin 12 (VE-cadherin 2) is expressed in endothelial, trophoblast, and mesangial cells. Exp Cell Res (2005) 0.94
Cooperation between β- and γ-cytoplasmic actins in the mechanical regulation of endothelial microparticle formation. FASEB J (2012) 0.94
Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro. J Biol Chem (2011) 0.94
Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling. FASEB J (2002) 0.94
Contribution of annexin 2 to the architecture of mature endothelial adherens junctions. Mol Cell Biol (2007) 0.94
Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression. AIDS (2005) 0.93
Fibrillin-1 genetic deficiency leads to pathological ageing of arteries in mice. J Pathol (2011) 0.92
Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells. Am J Physiol Cell Physiol (2010) 0.92
Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells. J Neurochem (2010) 0.92
Pcbs and tight junction expression. Environ Toxicol Pharmacol (2008) 0.92
Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity. J Cereb Blood Flow Metab (2010) 0.91
Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochem Pharmacol (2011) 0.91
Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies. Brain Res (2009) 0.90
Multilineage hematopoietic progenitor activity generated autonomously in the mouse yolk sac: analysis using angiogenesis-defective embryos. Int J Dev Biol (2003) 0.90
Unraveling the distinct distributions of VE- and N-cadherins in endothelial cells: a key role for p120-catenin. Exp Cell Res (2010) 0.90
Human brain endothelial cells are responsive to adenosine receptor activation. Purinergic Signal (2011) 0.90
Identification of peptide ligands for targeting to the blood-brain barrier. Pharm Res (2010) 0.90
Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype. PLoS One (2011) 0.90
Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct (2010) 0.90
PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells. J Neurochem (2007) 0.89
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma. J Neuroimmunol (2013) 0.89
IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells. J Neuroimmunol (2010) 0.89
Hyperosmotic stress induces Axl activation and cleavage in cerebral endothelial cells. J Neurochem (2008) 0.88
Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol (2014) 0.88
Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells. J Biol Chem (2010) 0.87
The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis. J Cell Sci (2004) 0.87
Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging. Chem Commun (Camb) (2010) 0.86
Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells. PLoS One (2012) 0.86
Cortical bone resorption following muscle paralysis is spatially heterogeneous. Bone (2011) 0.86
Europe-wide survey of teaching in geriatric medicine. J Am Geriatr Soc (2008) 0.86